Characterisation of the Role of Zinc in the Hepatitis C Virus NS2/3 Auto-cleavage and NS3 Protease Activities

Journal of Molecular Biology

Volumn 366, Issue 5, 2007, Pages 1652-1660

  Tedbury, Philip R ^a   Harris, Mark ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

hepatitis C virus; mutagenesis; NS2 3 auto cleavage; NS3 protease; zinc

Indexed keywords

CYSTEINE; HISTIDINE; PHENANTHROLINE; PROTEINASE; VIRUS GLYCOPROTEIN; ZINC;

AMINO TERMINAL SEQUENCE; ARTICLE; CHELATION; CONFORMATION; ESCHERICHIA COLI; GEOMETRY; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING;

ESCHERICHIA COLI; HEPATITIS C VIRUS;

EID: 33846809096     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.12.062     Document Type: Article

References (29)

1. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5 (2005) 558-567
2. Zoulim F., Chevallier M., Maynard M., and Trepo C. Clinical consequences of hepatitis C virus infection. Rev. Med. Virol. 13 (2003) 57-68
3. Lindenbach B.D., and Rice C.M. Unravelling hepatitis C virus replication from genome to function. Nature 436 (2005) 933-938
4. McLauchlan J., Lemberg M.K., Hope G., and Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 21 (2002) 3980-3988
5. Kolykhalov A.A., Mihalik K., Feinstone S.M., and Rice C.M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol. 74 (2000) 2046-2051
6. Welbourn S., Green R., Gamache I., Dandache S., Lohmann V., Bartenschlager R., et al. Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication. J. Biol. Chem. 280 (2005) 29604-29611
7. Lorenz I.C., Marcotrigiano J., Dentzer T.G., and Rice C.M. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 442 (2006) 831-835
8. Wu Z., Yao N.H., Le H.V., and Weber P.C. Mechanism of autoproteolysis at the NS2-NS3 junction of the hepatitis C virus polyprotein. Trends Biochem. Sci. 23 (1998) 92-94
9. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., et al. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis-C virus. J. Virol. 67 (1993) 4665-4675
10. Thibeault D., Maurice R., Pilote L., Lamarre D., and Pause A. In vitro characterization of a purified NS2/3 protease variant of hepatitis C virus. J. Biol. Chem. 276 (2001) 46678-46684
11. Grakoui A., McCourt D.W., Wychowski C., Feinstone S.M., and Rice C.M. A second hepatitis-C virus-encoded proteinase. Proc. Natl Acad. Sci. USA 90 (1993) 10583-10587
12. Reed K.E., Grakoui A., and Rice C.M. Hepatitis-C virus-encoded NS2-3 protease - cleavage-site mutagenesis and requirements for bimolecular cleavage. J. Virol. 69 (1995) 4127-4136
13. Santolini E., Pacini L., Fipaldini C., Migliaccio G., and LaMonica N. The NS2 protein of hepatitis-C virus is a transmembrane polypeptide. J. Virol. 69 (1995) 7461-7471
14. Kim J.L., Morgenstern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., et al. Crystal-structure of the hepatitis-C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87 (1996) 343-355
15. Love R.A., Parge H.E., Wickersham J.A., Hostomsky Z., Habuka N., Moomaw E.W., et al. The crystal-structure of hepatitis-C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc-binding site. Cell 87 (1996) 331-342
16. Yan Y.W., Li Y., Munshi S., Sardana V., Cole J.L., Sardana M., et al. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 angstrom resolution structure in a hexagonal crystal form. Protein Sci. 7 (1998) 837-847
17. Kuiken C., Yusim K., Boykin L., and Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 21 (2005) 379-384
18. Darke P.L., Jacobs A.R., Waxman L., and Kuo L.C. Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides. Implications for control of viral processing. J. Biol. Chem. 274 (1999) 34511-34514
19. Pallaoro M., Lahm A., Biasiol G., Brunetti M., Nardella C., Orsatti L., et al. Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein. J. Virol. 75 (2001) 9939-9946
20. Urbani A., Bazzo R., Nardi M.C., Cicero D.O., Defrancesco R., Steinkuhler C., and Barbato G. The metal binding site of the hepatitis C virus NS3 protease - a spectroscopic investigation. J. Biol. Chem. 273 (1998) 18760-18769
21. Barbato G., Cicero D.O., Nardi M.C., Steinkuhler C., Cortese R., De Francesco R., and Bazzo R. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. J. Mol. Biol. 289 (1999) 371-384
22. Yao N.H., Reichert P., Taremi S.S., Prosise W.W., and Weber P.C. Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease- helicase. Structure 7 (1999) 1353-1363
23. Di Marco S., Rizzi M., Volpari C., Walsh M.A., Narjes F., and Colarusso S. Inhibition of the hepatitis C virus NS3/4A protease - the crystal structures of two protease-inhibitor complexes. J. Biol. Chem. 275 (2000) 7152-7157
24. Yanagi M., StClaire M., Shapiro M., Emerson S.U., Purcell R.H., and Bukh J. Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology 244 (1998) 161-172
25. Aoubala M., Holt J., Clegg R.A., Rowlands D.J., and Harris M. The inhibition of cAMP-dependent protein kinase by full-length hepatitis C virus NS3/4A complex is due to ATP hydrolysis. J. Gen. Virol. 82 (2001) 1637-1646
26. Roques B.P., Fournie-Zaluski M.C., Soroca E., Lecomte J.M., Malfroy B., Llorens C., and Schwartz J.C. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 288 (1980) 286-288
27. Komiyama T., Aoyagi T., Takeuchi T., and Umezawa H. Inhibitory effects of phosphoramidon on neutral metalloendopeptidases and its application on affinity chromatography. Biochem. Biophys. Res. Commun. 65 (1975) 352-357
28. Brunner D.B., Desponds G., Biollaz J., Keller I., Ferber F., Gavras H., et al. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Br. J. Clin. Pharmacol. 11 (1981) 461-467
29. Parkin E.T., Trew A., Christie G., Faller A., Mayer R., Turner A.J., and Hooper N.M. Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alpha. Biochemistry 41 (2002) 4972-4981